These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 3083105

  • 1. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T, Himeno K, Mitani M, Mori K, Miake S, Nomoto K.
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [Abstract] [Full Text] [Related]

  • 2. Anti-tumor cytostatic mechanism and delayed-type hypersensitivity against a syngeneic murine tumor. Comparison between neonatally thymectomized mice and congenitally athymic nude mice.
    Mitani M, Mori K, Himeno K, Nomoto K.
    J Immunol; 1989 Mar 15; 142(6):2148-54. PubMed ID: 2493508
    [Abstract] [Full Text] [Related]

  • 3. Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages.
    Mitani M, Matsumoto T, Mori K, Miake S, Himeno K, Nomoto K.
    J Clin Lab Immunol; 1985 Oct 15; 18(2):97-101. PubMed ID: 3935795
    [Abstract] [Full Text] [Related]

  • 4. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC, Prager MD.
    Cancer Res; 1977 Feb 15; 37(2):507-13. PubMed ID: 832275
    [Abstract] [Full Text] [Related]

  • 5. Role of cytostasis in antitumor immunity against syngeneic X5563 plasmocytoma: comparative study of cytostasis and cytolysis using variant tumors and neonatally thymectomized mice.
    Mitani M, Himeno K, Mori K, Nomoto K.
    J Clin Lab Immunol; 1989 May 15; 29(1):45-52. PubMed ID: 2628584
    [Abstract] [Full Text] [Related]

  • 6. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M.
    Osaka Daigaku Shigaku Zasshi; 1990 Jun 15; 35(1):180-205. PubMed ID: 2135404
    [Abstract] [Full Text] [Related]

  • 7. Dissociation between cytotoxic activity and delayed hypersensitivity against syngeneic or allogeneic tumor grafts.
    Sato M, Nomoto K, Yano Y, Taniguchi K, Takeya K.
    Gan; 1976 Dec 15; 67(6):835-47. PubMed ID: 1088135
    [Abstract] [Full Text] [Related]

  • 8. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M, Matsuzaki G, Yoshikai Y, Kobayashi N, Kurosawa S, Takimoto H, Nomoto K.
    Cancer Res; 1993 Jan 01; 53(1):106-11. PubMed ID: 8093229
    [Abstract] [Full Text] [Related]

  • 9. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H, Fujiwara H, Takai Y, Izumi Y, Sano S, Tsuchida T, Hamaoka T.
    J Immunol; 1985 Sep 01; 135(3):2199-205. PubMed ID: 3894520
    [Abstract] [Full Text] [Related]

  • 10. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R, Yoneda Y, Kuriyama M, Kubota T.
    J Immunol; 1999 Jul 01; 163(1):148-54. PubMed ID: 10384111
    [Abstract] [Full Text] [Related]

  • 11. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun 01; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 12. Killing of tumor cells in vitro by macrophages from mice given injections of squalene-treated cell wall skeleton of Nocardia rubra.
    Ito M, Iizuka H, Masuno T, Yasunami R, Ogura T, Yamamura Y, Azuma I.
    Cancer Res; 1981 Jul 01; 41(7):2925-30. PubMed ID: 7248952
    [Abstract] [Full Text] [Related]

  • 13. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
    Engers HD, Lahaye T, Sorenson GD, Glasebrook AL, Horvath C, Brunner KT.
    J Immunol; 1984 Sep 01; 133(3):1664-70. PubMed ID: 6205090
    [Abstract] [Full Text] [Related]

  • 14. Marked reduction of subcutaneous tumor growth by intraperitoneal administration of recombinant human interleukin 2 with a cell accumulator, proteose-peptone, in mice.
    Tanida S, Uchida H, Taniguchi K, Nomoto K.
    Cancer Res; 1989 Jan 15; 49(2):284-8. PubMed ID: 2783379
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of xenograft. II. Cytostatic effector mechanism for xenograft rejection.
    Nomoto K, Terasaka R, Himeno K, Shiraishi M.
    Jpn J Exp Med; 1981 Apr 15; 51(2):81-7. PubMed ID: 6974263
    [Abstract] [Full Text] [Related]

  • 16. Evidence for cytostatic T cell activity in the effector mechanism against syngeneic TMT mammary tumor cells in mice.
    Kurata S, Tsuchiya T, Norimura T, Yamashita U.
    J Immunol; 1983 Jan 15; 130(1):496-500. PubMed ID: 6600195
    [Abstract] [Full Text] [Related]

  • 17. Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.
    Vaage J.
    Cancer Res; 1973 Mar 15; 33(3):493-503. PubMed ID: 4689898
    [No Abstract] [Full Text] [Related]

  • 18. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW, Kripke ML.
    J Immunol; 1977 Apr 15; 118(4):1483-7. PubMed ID: 66296
    [Abstract] [Full Text] [Related]

  • 19. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
    Ogura T.
    Gan To Kagaku Ryoho; 1986 Mar 15; 13(3 Pt 2):689-96. PubMed ID: 3083782
    [Abstract] [Full Text] [Related]

  • 20. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM, Zarling JM.
    J Immunol; 1983 Aug 15; 131(2):1017-23. PubMed ID: 6223084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.